The invention relates to pharmaceutical compositions comprising
gastrointestinal proliferative factor (GIPF) polynucleotides and
polypeptides. The invention further relates to the therapeutic use of
GIPF to prevent or treat conditions or disorders associated with the
degeneration of the epithelial mucosa.